Maine Medicine Weekly Update - April 16, 2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause
•  FDA Update & Statement on Johnson & Johnson COVID-19 Vaccine Pause Recommendation
•  Thrombotic Thrombocytopenia & J&J COVID Vaccine Response from the Manufacturer
•  Over 30 Percent of US Adults Fully Vaccinated, Maine Leads the Nation
•  Maine CDC COVID-19 Update for Clinicians with Stephen Sears, MD
•  Clinical Updates and Guidance Related to COVID-19
•  Medicare FFS Claims: 2% Payment Adjustment (Sequestration) Suspended Through December
•  MaineCare Updates: Upcoming Accountable Communities Public Webinar & Primary Care 2.0 Presentation Available Online
•  HealthCare Dive: Urgent Care Centers Draw Some ER Visits but Associated with Higher Spending Overall
•  Webinar for Medical Students April 22: So You Are Employed, Now What?
•  Next MMA Legislative Call Will Be Wednesday, April 21st
•  Maine Community Action Partnership is Working for a Successful Vaccine Roll Out for All
•  Maine Medical Association & ActionPPE Partner Again; This Time for FDA Approved Rapid Antigen Tests
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  Maine Legislature Week 14 Update
•  Maine Legislature Public Hearings, Work Sessions & New Bills
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  "Prescribing to Reduce Opioid Overdose Risk: How to Impact the Epidemic Within the Pandemic"
•  NAMI Maine Workshops in May & June: Suicide Prevention & Management for Clinical Staff
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  New Maine AAP Educational Webinar Series
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Nurse Practitioner
•  Executive Director
•  Medical Director - ME License Required
•  Practice Administrator
•  Physician
•  Psychiatric Nurse Practitioner

 

Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause

The MMA released the following media statement shortly after Tuesday’s US FDA recommendation, and Governor Mills’ call the pause administration of the Johnson & Johnson COVID vaccine.

 

 

The MMA released the following media statement shortly after Tuesday’s US FDA recommendation, and Governor Mills’ call the pause administration of the Johnson & Johnson COVID vaccine.

News: For Immediate Release

Additional Information Contact: 

Dan Morin, Director of Communications & Government Affairs 

(207) 838-8613 – mobile 

DMorin@MaineMed.com 

MMA PRESIDENT STATEMENT ON JOHNSON & JOHNSON VACCINE 

MANCHESTER, (April 13, 2021) --- Today, the US Food and Drug Administration and Centers for Disease Control and Prevention recommended a pause in the use of the coronavirus vaccine developed by Johnson & Johnson out of an abundance of caution after six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. 

Shortly after, the Maine Center for Disease Control and Prevention announced they were not aware of any reports of these cases in Maine residents. Given this recommendation, the State of Maine is also advising that providers pause administration of the Johnson & Johnson vaccine until the U.S. CDC’s scientific advisory committee has further reviewed the safety data. 

MMA President, Karen Saylor, M.D., applauded the move but cautioned, “The reported events are extremely rare, and it has not yet been proven that the vaccine caused the reported blood clots.” She added, “Pausing administration of J&J doses is the right move as all safety concerns should be investigated immediately and thoroughly. This shows our regulatory agencies are doing their job and placing safety first.” 

About the Maine Medical Association:

The MMA was founded in 1853 and represents all of Maine's physicians, residents & medical students across all clinical specialties, organizations, and practice settings.